Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Visualization of Phytophthora palmivora Infection in Oil Palm Leaflets with Fluorescent Proteins and Cell Viability Markers.

Ochoa JC, Herrera M, Navia M, Romero HM.

Plant Pathol J. 2019 Feb;35(1):19-31. doi: 10.5423/PPJ.OA.02.2018.0034. Epub 2019 Feb 1.

2.

A call to arms: Unifying the fight against resistance.

Kaushansky A, Hedstrom L, Goldman A, Singh J, Yang PL, Rathod PK, Cynamon M, Wodarz D, Mahadevan D, Tomaras A, Navia MA, Schiffer CA.

Sci Signal. 2018 Oct 23;11(553). pii: eaav0442. doi: 10.1126/scisignal.aav0442.

PMID:
30352947
3.

GTSO: Global Trace Synchronization and Ordering Mechanism for Wireless Sensor Network Monitoring Platforms.

Navia M, Campelo JC, Bonastre A, Ors R.

Sensors (Basel). 2017 Dec 23;18(1). pii: E28. doi: 10.3390/s18010028.

4.

Active Low Intrusion Hybrid Monitor for Wireless Sensor Networks.

Navia M, Campelo JC, Bonastre A, Ors R, Capella JV, Serrano JJ.

Sensors (Basel). 2015 Sep 18;15(9):23927-52. doi: 10.3390/s150923927.

5.

Synthesis of Aspartame by Thermolysin: An X-ray Structural Study.

Birrane G, Bhyravbhatla B, Navia MA.

ACS Med Chem Lett. 2014 Apr 10;5(6):706-10. doi: 10.1021/ml500101z. eCollection 2014 Jun 12.

6.

Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivity.

Longo KA, Govek EK, Nolan A, McDonagh T, Charoenthongtrakul S, Giuliana DJ, Morgan K, Hixon J, Zhou C, Kelder B, Kopchick JJ, Saunders JO, Navia MA, Curtis R, DiStefano PS, Geddes BJ.

J Pharmacol Exp Ther. 2011 Oct;339(1):115-24. doi: 10.1124/jpet.111.183764. Epub 2011 Jul 20. Erratum in: J Pharmacol Exp Ther. 2012 Mar;340(3):810.

PMID:
21775475
7.

Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial.

Macete EV, Sacarlal J, Aponte JJ, Leach A, Navia MM, Milman J, Guinovart C, Mandomando I, López-Púa Y, Lievens M, Owusu-Ofori A, Dubois MC, Cahill CP, Koutsoukos M, Sillman M, Thompson R, Dubovsky F, Ballou WR, Cohen J, Alonso PL.

Trials. 2007 Mar 26;8:11.

8.

Etiology of diarrhea in children younger than 5 years of age admitted in a rural hospital of southern Mozambique.

Mandomando IM, Macete EV, Ruiz J, Sanz S, Abacassamo F, Vallès X, Sacarlal J, Navia MM, Vila J, Alonso PL, Gascon J.

Am J Trop Med Hyg. 2007 Mar;76(3):522-7. Erratum in: Am J Trop Med Hyg. 2008 Jul;79(1):140.

PMID:
17360878
9.

Haematological and biochemical indices in young African children: in search of reference intervals.

Quintó L, Aponte JJ, Sacarlal J, Espasa M, Aide P, Mandomando I, Guinovart C, Macete E, Navia MM, Thompson R, Menéndez C, Alonso PL.

Trop Med Int Health. 2006 Nov;11(11):1741-8.

10.

Relationship between haemoglobin and haematocrit in the definition of anaemia.

Quintó L, Aponte JJ, Menéndez C, Sacarlal J, Aide P, Espasa M, Mandomando I, Guinovart C, Macete E, Hirt R, Urassa H, Navia MM, Thompson R, Alonso PL.

Trop Med Int Health. 2006 Aug;11(8):1295-302.

11.

Malaria: burden of disease.

Guinovart C, Navia MM, Tanner M, Alonso PL.

Curr Mol Med. 2006 Mar;6(2):137-40. Review.

PMID:
16515506
12.

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.

Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Aide P, Sigauque B, Milman J, Mandomando I, Bassat Q, Guinovart C, Espasa M, Corachan S, Lievens M, Navia MM, Dubois MC, Menendez C, Dubovsky F, Cohen J, Thompson R, Ballou WR.

Lancet. 2005 Dec 10;366(9502):2012-8.

PMID:
16338450
13.

Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.

Napper AD, Hixon J, McDonagh T, Keavey K, Pons JF, Barker J, Yau WT, Amouzegh P, Flegg A, Hamelin E, Thomas RJ, Kates M, Jones S, Navia MA, Saunders JO, DiStefano PS, Curtis R.

J Med Chem. 2005 Dec 15;48(25):8045-54. Erratum in: J Med Chem. 2007 Mar 8;50(5):1086.

PMID:
16335928
14.
15.

Genetic diversity of Shigella species from different intercontinental sources.

Navia MM, Gascón J, Vila J.

Infect Genet Evol. 2005 Oct;5(4):349-53. Epub 2005 Feb 17.

PMID:
16168941
16.

[Primary peritonitis in previously healthy children].

Navia MJ, Caroli PL.

An Pediatr (Barc). 2004 Dec;61(6):554-7. Spanish.

17.

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.

Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, Mandomando I, Spiessens B, Guinovart C, Espasa M, Bassat Q, Aide P, Ofori-Anyinam O, Navia MM, Corachan S, Ceuppens M, Dubois MC, Demoitié MA, Dubovsky F, Menéndez C, Tornieporth N, Ballou WR, Thompson R, Cohen J.

Lancet. 2004 Oct 16-22;364(9443):1411-20.

PMID:
15488216
18.

Macrocephaly-cutis marmorata telangiectatica congenita: report of six new patients and a review.

Lapunzina P, Gairí A, Delicado A, Mori MA, Torres ML, Goma A, Navia M, Pajares IL.

Am J Med Genet A. 2004 Sep 15;130A(1):45-51. Review.

PMID:
15368495
19.

[Mechanisms of resistance to beta lactams and nalidixic acid in clinical isolates of Salmonella enteritidis serotype Hadar and Bsilla].

Ruiz J, Navia MM, Marco F, Vila J.

Enferm Infecc Microbiol Clin. 2004 Apr;22(4):252-3. Spanish. No abstract available.

PMID:
15056446
20.

Molecular characterization of the integrons in Shigella strains isolated from patients with traveler's diarrhea.

Navia MM, Ruiz J, Vila J.

Diagn Microbiol Infect Dis. 2004 Mar;48(3):175-9.

PMID:
15023426
21.

Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain.

Ruiz J, Navia MM, Casals C, Sierra JM, Jiménez De Anta MT, Vila J.

Clin Microbiol Infect. 2003 Sep;9(9):907-11.

22.

[Intercontinental spread of a trimethoprim-resistant strain of Shigella flexneri].

Navia MM, Ruiz J, Vila J.

Enferm Infecc Microbiol Clin. 2003 Oct;21(8):401-3. Spanish.

PMID:
14525704
23.

Detection of dihydrofolate reductase genes by PCR and RFLP.

Navia MM, Ruiz J, Sanchez-Cespedes J, Vila J.

Diagn Microbiol Infect Dis. 2003 Aug;46(4):295-8.

PMID:
12944023
24.

Analysis of the clonal relationship among clinical isolates of Salmonella enterica serovar Infantis by different typing methods.

Merino LA, Ronconi MC, Navia MM, Ruiz J, Sierra JM, Cech NB, Lodeiro NS, Vila J.

Rev Inst Med Trop Sao Paulo. 2003 May-Jun;45(3):119-23. Epub 2003 Jul 8.

25.

Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections.

Teresa Tejedor M, Martín JL, Navia M, Freixes J, Vila J.

Vet Microbiol. 2003 Jul 30;94(4):295-301.

PMID:
12829383
26.

Clonal dissemination of Yersinia enterocolitica strains with various susceptibilities to nalidixic acid.

Sánchez-Céspedes J, Navia MM, Martínez R, Orden B, Millán R, Ruiz J, Vila J.

J Clin Microbiol. 2003 Apr;41(4):1769-71.

27.

Characterization of an integron carrying a new class D beta-lactamase (OXA-37) in Acinetobacter baumannii.

Navia MM, Ruiz J, Vila J.

Microb Drug Resist. 2002 Winter;8(4):261-5.

PMID:
12523622
28.

Distribution of beta-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different beta-lactam antibiotics.

Danes C, Navia MM, Ruiz J, Marco F, Jurado A, Jimenez de Anta MT, Vila J.

J Antimicrob Chemother. 2002 Aug;50(2):261-4.

PMID:
12161409
29.

High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.

Ruiz J, Gómez J, Navia MM, Ribera A, Sierra JM, Marco F, Mensa J, Vila J.

Diagn Microbiol Infect Dis. 2002 Apr;42(4):257-61.

PMID:
12007443
30.

Prevalence of the Sat gene among clinical isolates of Shigella spp. causing travelers' diarrhea: geographical and specific differences.

Ruiz J, Navia MM, Vila J, Gascón J.

J Clin Microbiol. 2002 Apr;40(4):1565-6. No abstract available.

31.
32.

Protein Crystals as Novel Catalytic Materials.

Margolin AL, Navia MA.

Angew Chem Int Ed Engl. 2001 Jun 18;40(12):2204-2222.

PMID:
11433482
33.

In vitro activity of rifaximin against bacterial enteropathogens causing diarrhoea in children under 5 years of age in Ifakara, Tanzania.

Sierra JM, Navia MM, Vargas M, Urassa H, Schellemberg D, Gascón J, Vila J, Ruiz J.

J Antimicrob Chemother. 2001 Jun;47(6):904-5. No abstract available.

PMID:
11389133
34.

In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea.

Sierra JM, Ruiz J, Navia MM, Vargas M, Vila J.

Antimicrob Agents Chemother. 2001 Feb;45(2):643--4. No abstract available.

35.

Two short peptides including segments of subunit A of Escherichia coli DNA gyrase as potential probes to evaluate the antibacterial activity of quinolones.

Marchetto R, Nicolás E, Castillo N, Bacardit J, Navia M, Vila J, Giralt E.

J Pept Sci. 2001 Jan;7(1):27-40.

PMID:
11245203
36.

Evaluation of insulin resistance in two kinds of South American camelids: llamas and alpacas.

Araya AV, Atwater I, Navia MA, Jeffs S.

Comp Med. 2000 Oct;50(5):490-4.

PMID:
11099130
37.

A chicken in every pot, thanks to sulfonamide drugs.

Navia MA.

Science. 2000 Jun 23;288(5474):2132-3. No abstract available.

PMID:
10896586
38.

Analysis of the mechanisms of quinolone resistance in clinical isolates of citrobacter freundii

Navia MM, Ruiz J, Ribera A, de Anta MT, Vila J.

J Antimicrob Chemother. 2000 Apr;45(4):556. No abstract available.

PMID:
10747842
39.

Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.

Navia MM, Ruiz J, Ribera A, de Anta MT, Vila J.

J Antimicrob Chemother. 1999 Dec;44(6):743-8. Erratum in: J Antimicrob Chemother 2000 Apr;45(4):556.

PMID:
10590274
40.

Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania.

Navia MM, Capitano L, Ruiz J, Vargas M, Urassa H, Schellemberg D, Gascon J, Vila J.

J Clin Microbiol. 1999 Oct;37(10):3113-7.

41.

Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania.

Menendez C, Sanchez-Tapias JM, Kahigwa E, Mshinda H, Costa J, Vidal J, Acosta C, Lopez-Labrador X, Olmedo E, Navia M, Tanner M, Rodes J, Alonso PL.

J Med Virol. 1999 Jul;58(3):215-20.

PMID:
10447415
42.

Molecular evidence of mother-to-infant transmission of hepatitis G virus among women without known risk factors for parenteral infections.

Menéndez C, Sánchez-Tapias JM, Alonso PL, Giménez-Barcons M, Kahigwa E, Aponte JJ, Mshinda H, Navia MM, Jiménez de Anta MT, Rodés J, Saiz JC.

J Clin Microbiol. 1999 Jul;37(7):2333-6.

43.

Rational design of new immunosuppressive drugs.

Navia MA.

Transplant Proc. 1999 Feb-Mar;31(1-2):1097-8. Review. No abstract available.

PMID:
10083489
44.

Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain.

Vila J, Ruiz J, Navia M, Becerril B, Garcia I, Perea S, Lopez-Hernandez I, Alamo I, Ballester F, Planes AM, Martinez-Beltran J, de Anta TJ.

J Clin Microbiol. 1999 Mar;37(3):758-61.

45.

Research in two large pediatric residencies in Argentina.

Lapunzina P, Navia M, Moreno P, Soler V, Meo M, Giubergia V.

Acad Med. 1998 Jul;73(7):803-5.

PMID:
9679472
46.

Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived beta-lactamase in Acinetobacter baumannii.

Vila J, Navia M, Ruiz J, Casals C.

Antimicrob Agents Chemother. 1997 Dec;41(12):2757-9.

47.

Protein-drug complexes important for immunoregulation and organ transplantation.

Navia MA.

Curr Opin Struct Biol. 1996 Dec;6(6):838-47. Review.

PMID:
8994885
49.

The Devi case and more.

Navia MA.

Science. 1995 Aug 25;269(5227):1035. No abstract available.

PMID:
7662030
50.

X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex.

Griffith JP, Kim JL, Kim EE, Sintchak MD, Thomson JA, Fitzgibbon MJ, Fleming MA, Caron PR, Hsiao K, Navia MA.

Cell. 1995 Aug 11;82(3):507-22.

Supplemental Content

Support Center